Showing 12 out of 2273 items
- CATIE NewsIn a U.S. study, hookup app users reported more condomless sex than non-users. However, participants who used apps were more likely to start PrEP when offered. ...
- CATIE NewsA French study compared neurocognitive function between people with and without HIV. HIV-positive participants were more likely to have some degree of ...
- Doravirine is available as a pill and sold under the brand name Pifeltro. It belongs to the class of anti-HIV drugs called non-nukes (NNRTIs). Doravirine is ...
- Fostemsavir is a drug that has completed phase III clinical trials. It is intended for use by people who have strains of HIV that are resistant to many classes ...
- HIV-positive people who doctors described as “heavily treatment-experienced” were enrolled in a study on fostemsavir called Brighte. Most participants had ...
- ViiV Healthcare has built at least one manufacturing facility to make fostemsavir. The factory should have some supplies of fostemsavir available toward the end ...
- The widespread availability of potent HIV treatment (ART) in Canada and other high-income countries has largely transformed HIV infection into a chronic ...
- CATIE NewsU.S. researchers studied the motor functions of 354 long-term survivors of HIV. 69% of participants had some degree of movement problems, such as muscle ...
- CATIE NewsSexual transmission of hepatitis C has been observed among men who have sex with men. A study of 429 men taking PrEP identified factors associated with ...